Chair, President and CEO Sharon Mates sold $12.7M of Intra-Cellular Therapies, Inc.

Sold$12,680,892

$66.27Price

191,362Shares

−15%Stake

What ITCI did after the filing

Prices for ITCI after this filing aren't in yet.

Traded Tue, Jan 16. Filed Thu, Jan 18, 7:47 PM ET, after the close. Not investment advice.